- Previous Close
0.100 - Open
0.100 - Bid 0.100 x --
- Ask 0.108 x --
- Day's Range
0.100 - 0.108 - 52 Week Range
0.025 - 0.250 - Volume
333,000 - Avg. Volume
1,419,661 - Market Cap (intraday)
479.997M - Beta (5Y Monthly) -0.04
- PE Ratio (TTM)
-- - EPS (TTM)
-0.090 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Aug 12, 2020
- 1y Target Est
--
Glory Health Industry Limited, an investment holding company, develops and operates of real estate properties in the People's Republic of China. The company operates through four segments: Property Development, Primary Land Construction and Development Services, Property Investment, and Property Management and Related Services. The Property Development segment develops and sells commercial and residential properties. The Primary Land Construction and Development Services segment provides primary land development services, including services for resettlement, and construction of land infrastructure and ancillary public facilities on land owned by the local governments. The Property Investment segment engages in the rental of investment properties. The Property Management and Related Services segment offers property management and related services. It primarily serves individual purchasers for residential properties, as well as various types of corporations and other business entities for commercial properties. The company was formerly known as Guorui Properties Limited and changed its name to Glory Health Industry Limited in July 2022. Glory Health Industry Limited was founded in 1994 and is headquartered in Beijing, China. Glory Health Industry Limited is a subsidiary of Alltogether Land Company Limited.
www.glorypty.com552
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 2329.HK
View MorePerformance Overview: 2329.HK
Trailing total returns as of 2/26/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2329.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2329.HK
View MoreValuation Measures
Market Cap
444.44M
Enterprise Value
24.05B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.20
Price/Book (mrq)
0.04
Enterprise Value/Revenue
11.02
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-17.47%
Return on Assets (ttm)
-0.19%
Return on Equity (ttm)
-2.79%
Revenue (ttm)
2.04B
Net Income Avi to Common (ttm)
-355.76M
Diluted EPS (ttm)
-0.090
Balance Sheet and Cash Flow
Total Cash (mrq)
210.06M
Total Debt/Equity (mrq)
161.31%
Levered Free Cash Flow (ttm)
-425.01M